UCSF Study Finds No Association Between Hair Dye And Non-Hodgkin Lymphoma

December 01, 1998

Researchers at the University of California San Francisco report good news for the large proportion of American women, and some men, who use hair color products. In a study that included 4,108 participants, researchers found that there is no association between normal use of hair color products and risk for non-Hodgkin's lymphoma (NHL), the fifth most common cancer in the United States among both women and men.

The results of the study will be published in the December 1 issue of the American Journal of Public Health.

"These are wonderfully negative results," said Elizabeth Holly, Ph.D., MPH, UCSF professor of cancer epidemiology studies and lead author of the study. "There have been some studies that have shown an association between use of hair color products and non-Hodgkin's lymphoma, but results were often based on a small number of people who used hair dye and got lymphoma."

She cited a 1992 study that concluded that women who ever used any type of hair color product were at a 50 percent increased risk for NHL. However, she said that the present study included twice as many women and four times the number of men with NHL who had used hair color products than the 1992 study and found no overall increased risk among these populations.

"The results of our study, the largest one ever conducted in this area, will hopefully make the large proportion of American women who color their hair feel much more comfortable about using these products," Holly said.

Between 20 to 40 percent of women in the U.S. use hair color products, and the percentage is even higher in other regions of the country such as the San Francisco Bay Area, where 56 percent of women, and 9 percent of men interviewed during the study reported ever using hair color products.

According to Holly, researchers found that these percentages regarding hair color use were exactly the same among populations of people with and without NHL. The similarity of these proportions supports the assertion that there is no associated risk of hair color product use and NHL.

"The results of our study indicate that hair dye use is an unlikely risk factor for non-Hodgkins lymphoma and this should prompt researchers to focus on other etiological clues associated with lymphoma such as medical history, diet, exercise, lifestyle and perhaps occupation," Holly said.

Besides investigating the association between hair product use and NHL during the study, UCSF researchers also examined various occupational and chemical exposures, sexual factors, allergies, and viruses as potential risk factors for the disease.

According to Holly, over the past two decades, the incidence of NHL among the American population has surpassed most other cancers; increasing 4 percent per year in men, and 3 percent per year in women. However, known risk factors only explain a small portion of the estimated rise in incidence of NHL that has occurred since the late 1940's. In addition, similar increases have been reported by other countries and cannot be accounted for by known changes in exposure or NHL diagnostic techniques.

Epidemiological studies have provided conflicting reports regarding the association between hair color use and cancer, Holly said. While early laboratory animal studies found that many hair color products were carcinogenic to varying degrees, subsequent research on hair color components found that, with normal use, these products did not cause cancer in humans.

In addition, over the past 20 years, the Food and Drug Administration has discontinued some hair color products that were considered carcinogenic in animals. But Holly said that critics of these animal studies assert that researchers used high concentrations that would not normally be used by humans to evaluate the risk of exposure to chemicals used in hair dyes.

The Northern California Cancer Center helped recruit patients for the study. They identified NHL patients between 21 and 74 years of age within one month of diagnosis with NHL in all of the 70 hospitals located in the six San Francisco Bay Area counties. 713 study participants recently diagnosed with NHL were identified and interviewed about their hair color product use. 1604 control subjects, who were identified using random digit dial and matched to NHL patients by gender, age within five years, and county of residence, were also interviewed about hair color product use.

Study participants were asked if they had used hair color products more than five times not including during the past year and, if so, the type of product used and age at first and last use, frequency of use per year, and colors of permanent dyes used.

The National Cancer Institute funded this study. Other researchers of the study include Chitra Lele, Ph.D.; and Paige M. Bracci, PMH, MS.
-end-


University of California - San Francisco

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.